Teva enters opioid settlement agreement with US state Rhode Island
Teva, lured by $40M tax break, packs its bags for New Jersey HQ move | Fierce Pharma
EU antitrust authorities launch probe of Teva over Copaxone drug | The Times of Israel
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Teva Pharmaceuticals to Cut 25% of Jobs in Huge Reshaping - The New York Times
Pharmaceutical Company Reaches Settlement With Oklahoma In Opioid Case : NPR
Teva and MedinCell Announce FDA Acceptance of New Drug Application for TV-46000/mdc-IRM as a Treatment for Patients with Schizophrenia | Business Wire
Teva Pharmaceutical CEO Shlomo Yanai delivers a press conference in Cologne, Germany, 18 March 2010. German generics producer Ratiopharm is sold to world's leading generic producer Teva Pharmaceutical at 3.625 billion euro.
Teva Reports First Quarter 2020 Financial Results | Business Wire
Teva Pharmaceuticals Launches Generic EpiPen for Children in US | The Jewish Press - JewishPress.com | Hana Levi Julian | 21 Av 5779 – August 21, 2019 | JewishPress.com
Teva Posts 2021 Earnings and Puts Opioid Litigation in Rearview Mirror | BioSpace
News & Media
Teva Pharmaceuticals on Twitter: "CEO Kåre Schultz and members of Teva's leadership team shared #quarterlyresults and updates during today's Q3 2021 #earnings webcast. Access a replay here:https://t.co/wDrj765YCy Forward-looking statements are subject to
Price-fixing lawsuit deals another blow to already fragile Teva, experts say | The Times of Israel
The Teva-Allergan deal shows why pharma mergers are booming | Fortune
Teva Pharmaceuticals - Wikipedia
Teva won't say whether R&D cuts include layoffs; Cipla inks deal for Iranian plant; | Fierce Pharma
Jury holds drugmaker Teva liable in opioid crisis | WLUK